Integrating multiple microarray datasets on oral squamous cell carcinoma to reveal dysregulated networks

Head and Neck

Volumn 34, Issue 12, 2012, Pages 1789-1797

  Liu, Zhongyu ^a,b   Niu, Yulong ^b   Li, Chao ^c   Yang, Yi ^b   Gao, Chunfang ^a  

^a No 150 Central Hospital of PLA   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN CANCER HOSPITAL   (China)

Author keywords

dysregulated pathway; gene expression; meta analysis; microarray; oral squamous cell carcinoma (OSCC)

Indexed keywords

COMPLEMENTARY DNA; RNA;

ARTICLE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOUTH SQUAMOUS CELL CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH;

CARCINOMA, SQUAMOUS CELL; DATABASES, GENETIC; DATABASES, NUCLEIC ACID; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CYTOADHESIN;

EID: 84869507665     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.22013     Document Type: Article

References (65)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M,. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15-36.
2. Canto MT, Devesa SS,. Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol 2002; 38: 610-617.
3. Scully C, Field JK, Tanzawa H,. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 2000; 36: 256-263.
4. Reibel J,. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003; 14: 47-62.
5. Nagpal JK, Das BR,. Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol 2003; 39: 213-221.
6. Otero-Rey E, García-García A, Barros-Angueira F, Torres-Español M, Gándara-Rey JM, Somoza-Martín M,. DNA microarrays in oral cancer. Med Oral 2004; 9: 288-292.
7. Russo G, Zegar C, Giordiano A,. Advantages and limitations of microarray technology in human cancer. Oncogene 2003; 22: 6497-6507.
8. Yu YH, Kuo HK, Chang KW,. The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review. PLoS One 2008; 3: e3215.
9. Estilo CL, O-charoenrat P, Talbot S, et al. Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 2009; 9: 11.
10. Severino P, Alvares AM, Michaluart P Jr, et al. Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites. BMC Res Notes 2008; 1: 113.
11. Moreau Y, Aerts S, De Moor B, De Strooper B, Dabrowski M,. Comparison and meta-analysis of microarray data: from the bench to the computer desk. Trends Genet 2003; 19: 570-577.
12. Ginos MA, Page GP, Michalowicz BS, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004; 64: 55-63.
13. Shimada K, Uzawa K, Kato M, et al. Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 2005; 92: 1915-1921.
14. Wu Z, Irizarry RA,. Preprocessing of oligonucleotide array data. Nat Biotechnol 2004; 22: 656-658; author reply 658.
15. Mann HB, Whitney DR,. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statist 1947; 18: 50-60.
16. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Statist Soc B 1995; 57: 289-300.
17. Storey JD, Tibshirani R,. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003; 100: 9440-9445.
18. Stouffer SA, Suchman EA, DeVinney LC, Star SA, Williams RM,. The American soldier: adjustment during Army life. Princeton, NJ: Princeton University Press; 1949. p 599.
19. Liptak, T. On the combination of independent tests. Magyar Tud Akad Mat Kutato Int Kzl 1958; 3: 171-179.
20. Marot G, Foulley JL, Mayer CD, Jaffrézic F,. Moderated effect size and p-value combinations for microarray meta-analyses. Bioinformatics 2009; 25: 2692-2699.
21. Folks JL,. Handbook of statistics v.4: Nonparametric methods. In:, Krishnaiah PR, Sen PK, editors. Combination of independent tests. North-Holland, Amsterdam: Elsevier Science Publishing Company; 1984. pp 113-121.
22. Setlur SR, Royce TE, Sboner A, et al. Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer. Cancer Res 2007; 67: 10296-10303.
23. Majeti R, Becker MW, Tian Q, et al. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Natl Acad Sci U S A 2009; 106: 3396-3401.
24. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102: 15545-15550.
25. Ye H, Yu T, Temam S, et al. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 2008; 9: 69.
26. Toruner GA, Ulger C, Alkan M, et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet 2004; 154: 27-35.
27. Colella S, Richards KL, Bachinski LL, et al. Molecular signatures of metastasis in head and neck cancer. Head Neck 2008; 30: 1273-1283.
28. Lim KP, Cirillo N, Hassona Y, et al. Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma. J Pathol 2011; 223: 459-469.
29. Kalluri R, Zeisberg M,. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
30. Yu H, Wang F, Tu K, Xie L, Li YY, Li YX,. Transcript-level annotation of Affymetrix probesets improves the interpretation of gene expression data. BMC Bioinformatics 2007; 8: 194.
31. Stalteri MA, Harrison AP,. Interpretation of multiple probe sets mapping to the same gene in Affymetrix GeneChips. BMC Bioinformatics 2007; 8: 13.
32. Li H, Zhu D, Cook M,. A statistical framework for consolidating "sibling" probe sets for Affymetrix GeneChip data. BMC Genomics 2008; 9: 188.
33. Cui X, Loraine AE,. Consistency analysis of redundant probe sets on affymetrix three-prime expression arrays and applications to differential mRNA processing. PLoS One 2009; 4: e4229.
34. Jaksik R, Polanska J, Herok R, Rzeszowska-Wolny J,. Calculation of reliable transcript levels of annotated genes on the basis of multiple probe-sets in Affymetrix microarrays. Acta Biochim Pol 2009; 56: 271-277.
35. Fortunel NO, Otu HH, Ng HH, et al. Comment on "'Stemness': transcriptional profiling of embryonic and adult stem cells" and "a stem cell molecular signature". Science 2003; 302: 393; author reply 393.
36. Song JY, Lee JK, Lee NW, Jung HH, Kim SH, Lee KW,. Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer. Int J Gynecol Cancer 2008; 18: 1051-1059.
37. Junnila S, Kokkola A, Mizuguchi T, et al. Gene expression analysis identifies over-expression of CXCL1, SPARC, SPP1, and SULF1 in gastric cancer. Genes Chromosomes Cancer 2010; 49: 28-39.
38. Rajkumar T, Vijayalakshmi N, Gopal G, et al. Identification and validation of genes involved in gastric tumorigenesis. Cancer Cell Int 2010; 10: 45.
39. Kretschmer C, Sterner-Kock A, Siedentopf F, Schoenegg W, Schlag PM, Kemmner W,. Identification of early molecular markers for breast cancer. Mol Cancer 2011; 10: 15.
40. Fischer H, Stenling R, Rubio C, Lindblom A,. Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 2001; 22: 875-878.
41. Oue N, Hamai Y, Mitani Y, et al. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 2004; 64: 2397-2405.
42. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H,. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005; 8: 86-94.
43. Chen J, Wu Q, Lu Y, et al. SPP1 promoter polymorphisms and glioma risk in a Chinese Han population. J Hum Genet 2010; 55: 456-461.
44. Suhr ML, Dysvik B, Bruland O, et al. Gene expression profile of oral squamous cell carcinomas from Sri Lankan betel quid users. Oncol Rep 2007; 18: 1061-1075.
45. Ko SY, Lin SC, Wong YK, Liu CJ, Chang KW, Liu TY,. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Cancer Lett 2007; 245: 33-43.
46. Ko SY, Lin SC, Chang KW, et al. Increased expression of amyloid precursor protein in oral squamous cell carcinoma. Int J Cancer 2004; 111: 727-732.
47. Stamenkovic I,. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003; 200: 448-464.
48. Kurahara S, Shinohara M, Ikebe T, et al. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999; 21: 627-638.
49. Sorsa T, Tjäderhane L, Salo T,. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004; 10: 311-318.
50. Thomas GT, Lewis MP, Speight PM,. Matrix metalloproteinases and oral cancer. Oral Oncol 1999; 35: 227-233.
51. Hong SD, Hong SP, Lee JI, Lim CY,. Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 2000; 36: 207-213.
52. Baker EA, Leaper DJ, Hayter JP, Dickenson AJ,. The matrix metalloproteinase system in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 2006; 44: 482-486.
53. Mäkelä M, Salo T, Uitto VJ, Larjava H,. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994; 73: 1397-1406.
54. Zeng ZS, Cohen AM, Guillem JG,. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 1999; 20: 749-755.
55. Kato K, Hara A, Kuno T, et al. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity. J Cancer Res Clin Oncol 2005; 131: 340-346.
56. Aznavoorian S, Moore BA, Alexander-Lister LD, Hallit SL, Windsor LJ, Engler JA,. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Cancer Res 2001; 61: 6264-6275.
57. Jones J, Sugiyama M, Watt FM, Speight PM,. Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium. J Pathol 1993; 169: 235-243.
58. Cortesina G, Sacchi M, Bussi M, et al. Integrin expression in head and neck cancers. Acta Otolaryngol 1995; 115: 328-330.
59. Pukkila M, Kosunen A, Ropponen K, et al. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma. J Clin Pathol 2007; 60: 267-272.
60. Sharon Stack M, Johnson JJ, Shi Z, Frazier S, Jiang R,. Functional alteration of oral squamous cell carcinoma aggressive behavior through uPAR-associated changes in gene expression. Oral Oncol Supp 2009; 3: 91.
61. Chang JT, Wang HM, Chang KW, et al. Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1. Int J Cancer 2005; 114: 942-949.
62. Koike H, Uzawa K, Nakashima D, et al. Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int J Oncol 2005; 27: 59-67.
63. Ikebe T, Takeuchi H, Jimi E, Beppu M, Shinohara M, Shirasuna K,. Involvement of proteasomes in migration and matrix metalloproteinase-9 production of oral squamous cell carcinoma. Int J Cancer 1998; 77: 578-585.
64. Fushimi K, Uzawa K, Ishigami T, et al. Susceptible genes and molecular pathways related to heavy ion irradiation in oral squamous cell carcinoma cells. Radiother Oncol 2008; 89: 237-244.
65. Cheong SC, Chandramouli GV, Saleh A, et al. Gene expression in human oral squamous cell carcinoma is influenced by risk factor exposure. Oral Oncol 2009; 45: 712-719.